Airain Ltd’s Intersect ENT, Inc XENT Stock Holding History

Airain Ltd’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-19,037	Closed	-$545K	–	1123
2015 Q2	$545K	Buy	+19,037	New	+$499K	0.03%	501

Other funds holding XENT

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Airain Ltd's XENT Position: Q3 2015 in Review

Airain Ltd sold out of Intersect ENT, Inc (XENT) in Q3 2015, closing a stake of 19,037 shares — an estimated $545K sold.

Airain Ltd first reported a position in XENT in Q2 2015 and held it in 1 quarter. The position peaked at $545K in Q2 2015. 125 funds tracked by Wall St. Rank hold XENT as of Q3 2015.

Airain Ltd reported no remaining Intersect ENT, Inc position as of Q3 2015 after selling out during the quarter.
Airain Ltd sold 19,037 Intersect ENT, Inc shares in Q3 2015, an estimated $545K.
Airain Ltd first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 1 quarter.
Airain Ltd's Intersect ENT, Inc position peaked at $545K in Q2 2015.
125 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2015.

Based on Airain Ltd's 13F filing for Q3 2015, filed 9 Nov 2015.